ClinicalTrials.gg

Drug class

Proton Pump Inhibitors clinical trials

A class of medicines: the studies that test any of its 9 members, each study once. Members are as MeSH files each medicine’s actions, and as the NCI Thesaurus classes newer ones.

studies test it
885
open now
51
in phase 3
180
first study started
1995

Keep track of what changes. Save the proton pump inhibitors studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

Medicines in this class

Studies that test each. A study of two counts under both, and once above.

Omeprazole, sodium bicarbonate drug combination
5

Studies by the year they started

872 studies that test it; most in 2006 (64)

Studies that test Proton Pump Inhibitors, by start year
YearStudies
19952
19962
19984
19991
20004
200114
200224
200328
200432
200544
200664
200733
200859
200936
201053
201141
201228
201346
201442
201532
201632
201730
201837
201924
202028
202124
202220
202323
202433
202519
202613

By phase

A phase 1/2 study counts in both.

Early Phase 1
9
Phase 1
286
Phase 2
92
Phase 3
180
Phase 4
237
No phase
109

What it is tested for

Each study’s main condition, where its own words name it.

Who runs them

Industry 448 · Other 437

AstraZeneca (97) · Takeda (51) · Boehringer Ingelheim (23) · Pfizer (15) · National Taiwan University Hospital (14) · Il-Yang Pharm. Co., Ltd. (13) · Eisai Inc. (12) · Chinese University of Hong Kong (12)

Studies

Open first, then newest update. How each study uses a medicine is read from its arms, and is right about nine times in ten.

Testing one of them · 885

See all 885 studies that test one of the proton pump inhibitors →

Codes

What other systems call Proton Pump Inhibitors · ClinicalTrials.gg INT008901

  • MeSH (NLM) D054328Proton Pump InhibitorsOne source ClinicalTrials.gov

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.